Two independent lot files
PT-141 and MOTS-C each ship with their own paperwork.
Sale
Performance Bundle
$104.98
Purity (HPLC)≥99%
Storage2–8 °C
- Third-party testedIndependent lab verified
- Batch-specific COAsAvailable for each compound in the bundle
- Tracked shippingDispatched with tracking
- Secure checkoutEncrypted payment
Questions before ordering? Our team can confirm documentation, stock and shipping.
- Research Use Only
- Third-Party Tested
- COA Access Available
- Laboratory Use Only
Key Specifications
Details for each compound are separated in the table below.
| Compound | PT-141 | MOTS-C |
|---|---|---|
| Quantity | 10mg | 10mg |
| Product format | Research-grade cyclic heptapeptide | Research-grade mitochondrial-derived peptide |
| Intended use | Laboratory research only | Laboratory research only |
| Documentation | COA available through our COA library | COA available through our COA library |
| Related category | Neuropeptide & CNS Research | Mitochondrial & Metabolic Peptide Research |
Research Use Only
Neither compound in this stack carries approval for human or animal administration, diagnosis, or treatment. Distribution is limited strictly to laboratories and qualified researchers.
Check the compliance section and each compound's storage page ahead of checkout.
What is the Libido Vitality Research Stack?
PT-141, also known as bremelanotide, is a synthetic derivative of alpha-MSH that binds melanocortin receptors, primarily MC4R and MC3R, in the hypothalamus. That binding triggers a cAMP-PKA signaling cascade in the medial preoptic area that drives dopamine release, a mechanism entirely separate from peripheral vascular pathways.
MOTS-C has nothing to do with receptor binding at all. It's a 16-amino-acid peptide encoded within mitochondrial DNA that translocates to the nucleus under metabolic stress and activates AMPK, connecting cellular energy status to broader physiological signaling.
Pairing a central-nervous-system receptor agonist with a mitochondria-encoded metabolic peptide gives a lab two independent variables to study side by side, one rooted in brain signaling, the other in cellular bioenergetics.
Product Details
The two compounds don't overlap mechanistically, which is exactly what makes them useful to compare in the same study.
- PT-141Cyclic heptapeptide melanocortin receptor agonist studied for central dopaminergic activation via MC4R and MC3R.
- MOTS-CMitochondrially encoded peptide studied for AMPK-linked signaling and metabolic stress adaptation.
Purity Verification and COA Access
Both vials in this stack carry their own lot-specific records, so a researcher can confirm the exact batch on hand instead of relying on a single certificate for the pair.
Why Cellugenix for Libido Vitality Research Stack?
This two-compound stack follows the same documentation standard as every listing in our catalog.
Third-party verification
Identity and purity for each batch are confirmed outside our facility.
Laboratory-only sales
Neither compound is marketed beyond research use.
Tracked delivery
Both vials ship together under one tracking number.
Cushioned packing
Each item is secured individually within the shipment.
Storage and Handling
A central-acting peptide and a mitochondrial peptide don't share identical stability needs, so check each one on its own terms.
- Compound-specific notesPT-141 and MOTS-C each have distinct temperature and reconstitution guidance.
- Keep records separateMatch each COA to its corresponding vial for easy reference.
- Review before prepOpen the individual handling page for either compound before reconstituting it.
Related Research Category
This stack spans two categories within the Cellugenix catalog.
Quality and Documentation
Reference pages for testing standards and ordering policy.
Frequently Asked Questions
What two compounds make up the Libido Vitality Research Stack, and in what amounts?
PT-141 at 10mg and MOTS-C at 10mg, each shipped as an individually documented vial.
PT-141 and MOTS-C seem unrelated. What's the reasoning behind pairing them?
Their mechanisms don't overlap on purpose. PT-141 works through central melanocortin receptor signaling, while MOTS-C operates at the mitochondrial level, giving researchers two distinct physiological variables in one order.
Is a COA supplied for both compounds individually?
Yes, PT-141 and MOTS-C each carry a separate batch record accessible through the COA library.
Do PT-141 and MOTS-C require the same storage approach?
No. Their stability profiles differ, so consult the individual handling page for each compound before use.
Does PT-141 act on the same pathway as PDE5 inhibitors like sildenafil?
No. Research shows PT-141 works centrally through hypothalamic MC4R activation and downstream dopamine release, a mechanism distinct from the peripheral vascular pathway that PDE5 inhibitors target.
Need Product Support?
Have a question about tracking your shipment, verifying a lot number, or an issue with how an item arrived? Reach out to our support team and we'll help resolve it.
